Clinical Trials
11
Active:3
Completed:8
Trial Phases
2 Phases
Phase 1:8
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)β’ Click on a phase to view related trials
Phase 1
8 (72.7%)Phase 2
3 (27.3%)Safety, Blood Levels and Effects of AUT00201 in Patients With MEAK
- First Posted Date
- 2023-05-24
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Autifony Therapeutics Limited
- Target Recruit Count
- 6
- Registration Number
- NCT05873062
- Locations
- πΊπΈ
University of Pennsylvania, Penn Epilepsy Center, Philadelphia, Pennsylvania, United States
Safety, Blood Levels and Effects of AUT00201
- First Posted Date
- 2019-11-08
- Last Posted Date
- 2021-01-13
- Lead Sponsor
- Autifony Therapeutics Limited
- Target Recruit Count
- 80
- Registration Number
- NCT04158453
- Locations
- π¬π§
Hammersmith Medicines Research, London, United Kingdom
Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers.
- First Posted Date
- 2017-05-24
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Autifony Therapeutics Limited
- Target Recruit Count
- 24
- Registration Number
- NCT03164876
- Locations
- π¬π§
King's College London Institute of Psychiatry, Psychology and Neuroscience (IoPPN), London, United Kingdom
A Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Males
Phase 1
Completed
- Conditions
- Schizophrenia
- Interventions
- Drug: High dose AUT00206 2000 mgDrug: Low dose AUT00206 800mgDrug: PlaceboOther: Saline
- First Posted Date
- 2016-10-17
- Last Posted Date
- 2017-11-27
- Lead Sponsor
- Autifony Therapeutics Limited
- Target Recruit Count
- 22
- Registration Number
- NCT02935725
- Locations
- π¬π§
University Of Manchester, London, United Kingdom
Evaluating Possible Improvement in Speech and Hearing Tests After 28 Days of Dosing of the Study Drug AUT00063 Compared to Placebo (QuicKfire)
- First Posted Date
- 2016-07-14
- Last Posted Date
- 2017-05-24
- Lead Sponsor
- Autifony Therapeutics Limited
- Target Recruit Count
- 15
- Registration Number
- NCT02832128
- Locations
- π¬π§
University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
π¬π§Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
π¬π§Royal National Throat, Nose and Ear Hospital, London, United Kingdom
- Prev
- 1
- 2
- Next
News
No news found